GGrantIndex
← Leaderboards

Robert S Mittler

Emory University

Google Scholar ↗PubMed ↗ORCID ↗
$4,403,240
Attributed
$4,403,240
Total exposure
22
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $718.2K · FY2005–10
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10

Funding mix

By agency

NIH$4,403,240 · 22

By mechanism

R01$3,097,490 · 2
P51$724,649 · 17
R21$320,000 · 1
U19$261,101 · 1
P01$0 · 1

Top collaborators

No co-investigators on record.

Most similar at Emory University

Same institution · by research overlap

Others in their field

Top investigators on “Research Personnel”

Research focus

Research PersonnelSourceResourcesUnited States National Institutes Of HealthFundingComputer Retrieval Of Information On Scientific Projects DatabaseInstitutionPrimatesGrantT-LymphocyteInfectionCd8b1 GeneImmune ResponseSignal TransductionProgramsMediatingDendritic CellsResponseImmunityAnthrax VaccinesCd4 Positive T LymphocytesEventLymphocytic Choriomeningitis VirusMacaca Mulatta

Grant awards (33)

CD137 SIGNALS IN DC DURING AG-PRIMING INDUCES TOLERANCE$54,827
P51 · FY2010 · RR · contact PI
ANTHRAX VACCINE RESEARCH PROGRAM$43,862
P51 · FY2010 · RR · contact PI
CD137 signals in DC during Ag-priming induces tolerance$392,994
R01 · FY2009 · AI · contact PI
CD137 SIGNALS IN DC DURING AG-PRIMING INDUCES TOLERANCE$56,690
P51 · FY2009 · RR · contact PI
ANTHRAX VACCINE RESEARCH PROGRAM$43,907
P51 · FY2009 · RR · contact PI
CD137 signals in DV during Ag-priming induces tolerance$392,994
R01 · FY2008 · AI · contact PI
HUMAN MONOCLONAL ANTIBODIES TO CATEGORY A PATHOGENS$261,101
U19 · FY2008 · AI · contact PI
CD137 SIGNALS IN DC DURING AG-PRIMING INDUCES TOLERANCE$35,600
P51 · FY2008 · RR · contact PI
ANTHRAX VACCINE RESEARCH PROGRAM$28,536
P51 · FY2008 · RR · contact PI
CD137 signals in DV during Ag-priming induces tolerance$400,606
R01 · FY2007 · AI · contact PI
CD137 SIGNALS IN DC DURING AG-PRIMING INDUCES TOLERANCE$39,499
P51 · FY2007 · RR · contact PI
ANTHRAX VACCINE RESEARCH PROGRAM$31,598
P51 · FY2007 · RR · contact PI
CD137 signals in DV during Ag-priming induces tolerance$412,571
R01 · FY2006 · AI · contact PI
EFFECT OF ANTI-4 1BB ON SIV SPECIFIC CELLULAR IMMUNITY$59,665
P51 · FY2006 · RR · contact PI
CD137 SIGNALS IN DC DURING AG-PRIMING INDUCES TOLERANCE$40,116
P51 · FY2006 · RR · contact PI
ANTHRAX VACCINE RESEARCH PROGRAM$40,116
P51 · FY2006 · RR · contact PI
CD137 signals in DV during Ag-priming induces tolerance$359,125
R01 · FY2005 · AI
Analysis of Anti41BB Mediated Tumor Immunity$284,800
R01 · FY2005 · CA
ANTHRAX VACCINE RESEARCH PROGRAM$32,021
P51 · FY2005 · RR
EFFECT OF ANTI-4 1BB ON SIV SPECIFIC CELLULAR IMMUNITY$28,325
P51 · FY2005 · RR
Analysis of Anti41BB Mediated Tumor Immunity$284,800
R01 · FY2004 · CA
ANTHRAX VACCINE RESEARCH PROGRAM$35,765
P51 · FY2004 · RR
EFFECT OF ANTI-4 1BB ON SIV SPECIFIC CELLULAR IMMUNITY$27,918
P51 · FY2004 · RR
ANTI-CD137 BLOCKS PROGRESSION OF SLE IN PROTEINURIC MICE$18,585
P51 · FY2004 · RR
ANALYSIS OF ANIT 4-1BB MEDIATED TUMOR IMMUNITY$18,585
P51 · FY2004 · RR
Analysis of Anti41BB Mediated Tumor Immunity$284,800
R01 · FY2003 · CA
ANTHRAX VACCINE RESEARCH PROGRAM$31,173
P51 · FY2003 · RR
EFFECT OF ANTI-4 1BB ON SIV SPECIFIC CELLULAR IMMUNITY$25,567
P51 · FY2003 · RR
ANALYSIS OF ANIT 4-1BB MEDIATED TUMOR IMMUNITY$16,147
P51 · FY2003 · RR
ANTI-CD137 BLOCKS PROGRESSION SYSTEMIC LUPUS ERYTHEMATOSUS IN PROTEINURIC MICE$16,147
P51 · FY2003 · RR
Analysis of Anti41BB Mediated Tumor Immunity$284,800
R01 · FY2002 · CA
Core--Antibody Production Facility$0
P01 · FY2002 · AI
EFFECTS OF ANTI-4-1BB ON SIV-SPECIFIC CELLULAR IMMUNITY$320,000
R21 · FY2001 · AI